Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor

被引：4
|
作者：
Robles, Joanna [1 ]
Keskinyan, Vahakn S. [2 ]
Thompson, Matthew [3 ]
Davis, Joseph T. [4 ]
Van Mater, David [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Hematol Oncol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[3] Wake Forest Baptist Hosp, Dept Radiol, Winston Salem, NC USA
[4] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA
来源：
PEDIATRIC HEMATOLOGY AND ONCOLOGY | 2020年 / 37卷 / 05期
关键词：
AGGRESSIVE FIBROMATOSIS; PHASE-II; MANAGEMENT; CHILDREN; SARCOMA; BIOLOGY; TISSUE;
D O I：
10.1080/08880018.2020.1735591
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：445 / 449
页数：5
相关论文
共 50 条
  • [21] Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors.
    Ferhatoglu, Ferhat
    Paksoy, Nail
    Dogan, Izzet
    Ak, Naziye
    Pehlivan, Metin
    Ekenel, Meltem
    Basaran, Mert
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] A CASE OF DESMOID TUMOR CONTROLLED WITH SORAFENIB BECAUSE OF INTOLERANCE TO MULTI-AGENT CHEMOTHERAPY
    Ochiai, Hidemasa
    Miyazaki, Bunpei
    Hirose, Kiyoharu
    Ando, Kumiko
    Taneyama, Yuichi
    Kakuda, Harumi
    Tonoike, Yurie
    Arimoto, Yukiko
    Nakano, Atsuko
    Naruke, Yuki
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [23] Sorafenib and Triptolide as Combination Therapy for Hepatocellular Carcinoma
    Alsaied, Osama
    Sangwan, Veena
    Banerjee, Sulagna
    Chugh, Rohit
    Saluja, Ashok
    Vickers, Selwyn M.
    Jensen, Eric
    HEPATOLOGY, 2013, 58 : 1073A - 1073A
  • [24] Sorafenib and triptolide as combination therapy for hepatocellular carcinoma
    Alsaied, Osama A.
    Sangwan, Veena
    Banerjee, Sulagna
    Krosch, Tara C.
    Chugh, Rohit
    Saluja, Ashok
    Vickers, Selwyn M.
    Jensen, Eric H.
    SURGERY, 2014, 156 (02) : 270 - 279
  • [25] Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma
    Yen, Tsai-Hung
    Chang, Chung-Hsin
    Shiu, Sz-Iuan
    CASE REPORTS IN GASTROENTEROLOGY, 2020, 14 (02) : 367 - 372
  • [26] NONCYTOTOXIC DRUG-THERAPY FOR INTRAABDOMINAL DESMOID TUMOR IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS
    TSUKADA, K
    CHURCH, JM
    JAGELMAN, DG
    FAZIO, VW
    MCGANNON, E
    GEORGE, CR
    SCHROEDER, T
    LAVERY, I
    OAKLEY, J
    DISEASES OF THE COLON & RECTUM, 1992, 35 (01) : 29 - 33
  • [27] Comparison of Clinical Outcomes between the recurrent advanced Hepatocellular Carcinoma patients with Sorafenib treatment and the patients with Sorafenib plus Interferon combination therapy
    Doi, Hisakazu
    HEPATOLOGY, 2013, 58 : 1251A - 1252A
  • [28] REMISSION OF RECURRENT DESMOID TUMOR UNDER IFOSFAMIDE THERAPY
    HOFFMANN, W
    WEIDMANN, B
    HANSMANN, E
    GRUNDMANN, E
    SEEBER, S
    TUMORDIAGNOSTIK & THERAPIE, 1987, 8 (03) : 126 - 128
  • [29] DESMOID TUMOR - PARTIAL-RESPONSE WITH TAMOXIFEN THERAPY
    GOUYON, B
    DUCREUX, M
    ROUGIER, P
    BERTHELOT, G
    LASSER, P
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1994, 18 (8-9): : 792 - 794
  • [30] A Desmoid Tumor Responding to Systemic Therapy With Tamoxifen and Sulindac
    Choudhury, Hasan
    Abidoye, Oluseyi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
12345